Case Studies for Overcoming Challenges in Using Big Data in Cancer

Author:

Sweeney Shawn M.1ORCID,Hamadeh Hisham K.2ORCID,Abrams Natalie3ORCID,Adam Stacey J.4ORCID,Brenner Sara5ORCID,Connors Dana E.4ORCID,Davis Gerard J.6ORCID,Fiore Louis D.7ORCID,Gawel Susan H.6ORCID,Grossman Robert L.8ORCID,Hanlon Sean E.9ORCID,Hsu Karl10ORCID,Kelloff Gary J.11ORCID,Kirsch Ilan R.12ORCID,Louv Bill13ORCID,McGraw Deven14ORCID,Meng Frank15ORCID,Milgram Daniel16ORCID,Miller Robert S.17ORCID,Morgan Emily4ORCID,Mukundan Lata16ORCID,O'Brien Thomas18ORCID,Robbins Paul18ORCID,Rubin Eric H.19ORCID,Rubinstein Wendy S.5,Salmi Liz20ORCID,Schaller Teilo H.13ORCID,Shi George6ORCID,Sigman Caroline C.15ORCID,Srivastava Sudhir21ORCID

Affiliation:

1. 1American Association for Cancer Research, Philadelphia, Pennsylvania.

2. 2Genmab, Princeton, New Jersey.

3. 3Division of Cancer Prevention, Early Detection Research Network, National Cancer Institute, Rockville, Maryland.

4. 4Foundation for the National Institutes of Health, Bethesda, Maryland.

5. 5Office of In Vitro Diagnostics, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland.

6. 6Abbott Diagnostics Division, Abbott Laboratories, Lake Forest, Illinois.

7. 7Boston University School of Medicine, Boston and New England Department of Veterans Affairs, Bedford, Massachusetts.

8. 8Center for Translational Data Science, The University of Chicago, Chicago, Illinois.

9. 9Center for Strategic Scientific Initiatives, National Cancer Institute, Bethesda, Maryland.

10. 10Sanofi, Bridgewater, New Jersey.

11. 11Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.

12. 12Adaptive Biotechnologies, Seattle, Washington.

13. 13Project Data Sphere, Morrisville, North Carolina.

14. 14Ciitizen Platform at Invitae, San Francisco, California.

15. 15Boston University and Veterans Administration Boston Healthcare System, Boston, Massachusetts.

16. 16CCS Associates, San Jose, California.

17. 17CancerLinQ, American Society of Clinical Oncology, Alexandria, Virginia.

18. 18Pfizer, Brooklyn, New York.

19. 19Merck, New York, New York.

20. 20Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

21. 21Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland.

Abstract

AbstractThe analysis of big healthcare data has enormous potential as a tool for advancing oncology drug development and patient treatment, particularly in the context of precision medicine. However, there are challenges in organizing, sharing, integrating, and making these data readily accessible to the research community. This review presents five case studies illustrating various successful approaches to addressing such challenges. These efforts are CancerLinQ, the American Association for Cancer Research Project GENIE, Project Data Sphere, the National Cancer Institute Genomic Data Commons, and the Veterans Health Administration Clinical Data Initiative. Critical factors in the development of these systems include attention to the use of robust pipelines for data aggregation, common data models, data deidentification to enable multiple uses, integration of data collection into physician workflows, terminology standardization and attention to interoperability, extensive quality assurance and quality control activity, incorporation of multiple data types, and understanding how data resources can be best applied. By describing some of the emerging resources, we hope to inspire consideration of the secondary use of such data at the earliest possible step to ensure the proper sharing of data in order to generate insights that advance the understanding and the treatment of cancer.

Funder

Foundation for the National Institutes of Health

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3